fbpx
September 2, 2020

Alternativas “completamente naturales” para la disfunción eréctil: una propuesta riesgosa

English Subscríbase para recibir artículos para el consumidor en español por email. ¡Hombres, tengan cuidado! Los productos que se comercializan erróneamente como “suplementos nutricionales” o “dietéticos” […]
September 2, 2020

Tome buenas decisiones sobre su salud: Cómo obtener la información que necesita

English Cuando su doctor le prescribe un medicamento para su hijo, ¿sabe cuál es dosis correcta o cómo medirla? Cuando recibe un análisis del laboratorio y […]
September 2, 2020

1 Party At A Time – 609781 – 09/01/2020

Product: Drugs Recipient: Recipient Name Dmitry Kats 1 Party At A Time 700 Bolinwood Dr., Apt. 26 CChapel Hill, NC 27514United States [email protected] Date:     September 1, […]
September 1, 2020

The Protein Shoppe, LLC Issues Voluntary Nationwide Recall of the “Red- E” Male Enhancement Tablet Due to the Presence of Undeclared Sildenafil

Summary Company Announcement Date: September 01, 2020 FDA Publish Date: September 01, 2020 Product Type: Drugs Reason for Announcement: Recall Reason Description Product contains undeclared sildenafil […]
September 1, 2020

FDA approves Onureg (azacitidine tablets) for acute myeloid leukemia

On September 1, 2020, the Food and Drug Administration approved azacitidine tablets (ONUREG®, Celgene Corporation) for continued treatment of patients with acute myeloid leukemia who achieved […]
September 1, 2020

CDER-CFSAN Agreement

Inter-center Agreement between the Center for Drug Evaluation and Research and the Center for Food Safety and Applied Nutrition to Assist FDA in Implementing the Drug […]
September 1, 2020

FDA Provides Guidance to Industry for Detecting and Preventing Nitrosamines in Drugs

For Immediate Release: September 01, 2020 Statement From: Statement Author Leadership Role Commissioner of Food and Drugs – Food and Drug Administration Stephen M. Hahn M.D. […]
September 1, 2020

FDA approves weekly therapy for adult growth hormone deficiency

[9/1/2020] The U.S. Food and Drug Administration approved Sogroya (somapacitan) on August 28 for adults with growth hormone deficiency. Sogroya is the first human growth hormone […]
September 1, 2020

Control of Nitrosamine Impurities in Human Drugs

Docket Number: FDA-2020-D-1530 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research This guidance recommends steps manufacturers of APIs and drug products should take […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0